Karim Saad Temsamani - Jan 1, 2024 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Chief Executive Officer, Director
Signature
/s/ Nick Lynton, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
Jan 1, 2024
Transactions value $
-$241,826
Form type
4
Date filed
1/3/2024, 08:00 PM
Previous filing
Dec 5, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Options Exercise +50K +19.32% 309K Jan 1, 2024 Direct F1
transaction CDLX Common Stock Sale -$242K -31.1K -10.08% $7.77 278K Jan 3, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDLX Restricted Stock Unit Options Exercise $0 -50K -50% $0.00 50K Jan 1, 2024 Common Stock 50K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
F2 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on January 1, 2024.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $7.50 to $8.3825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
F4 This RSU award was originally for 200,000 shares. 25% of the RSU award vested on each of July 1, 2023, October 1, 2023 and January 1, 2024. An additional 25% of the RSU award shall vest on April 1, 2024 subject to the Reporting Person's continuous service with the Issuer through the vesting date.